Abbott Nutritions EASA Brand to Enter into Relationship With the National Basketball Players Association
Abbott, 11/21/2006  Free full text

1 Community Pharmacies Launch Initiative for Safe Medication Disposal U.S. Pharmacist, June 10, 2010    Free full text

2 Drugs and indications recently approved by the FDA Formulary , June 10, 2010    Free full text

3 FDA warns against swallowing OTC Benadryl gel American Pharmacists Association, June 4, 2010    Free full text

4 New erectile dysfunction treatment STAXYN approved in the U.S. BayNews International, June 28, 2010    Free full text

5 How to Start Your Social Media Strategy PharmExec, June 1, 2010

6 Natural Balance Pet Foods, Inc. announces a voluntary recall of Natural Balance Sweet Potato & Chicken Dry Dog Food Due to a Possible Health Risk FDA , June 21, 2010

7 What We Learned from H1N1. Part 1: MedImmune BioPharm, June 11, 2010    Free full text

8 Teva Announces Launch of Generic Yaz Tablets Teva Pharmaceutical Industries, June 2, 2010    Free full text

9 FDA updates U.S. product labels for LABA-containing medications including AstraZeneca's SYMBICORT AstraZeneca, June 3, 2010    Free full text

10 FDA approved VIMOVO for arthritis patients at risk of developing NSAID-associated gastric ulcers AstraZeneca, June 25, 2010    Free full text

11 Prolia (Denosumab) Granted Marketing Authorization in the European Union Amgen, June 1, 2010    Free full text

12 FDA approves new treatment for Pompe disease American Pharmacists Association, June 16, 2010    Free full text

13 The US Food and Drug Administration Approves a New Gaucher Disease Drug Gastroenterology, June 8, 2010

14 FDA OKs Wearable Monitor HealthDataManagement, June 4, 2010

15 AVI BioPharma Discloses New Contract with U.S. Government For Up To $18 Million to Advance Development of AVI-7100 as H1N1 Flu Therapeutic AVI BioPharma, June 8, 2010    Free full text

16 Enabling individualized therapy through nanotechnology Pharmacological Research , June 25, 2010

17 Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing Pharmaceutical Technology, June 7, 2010    Free full text

18 Pivotal Phase III trial of Novartis drug Afinitor met primary endpoint in study of patients with advanced pancreatic neuroendocrine tumors Novartis, June 4, 2010    Free full text

19 Sagent recalls metronidazole injection due to nonsterility American Pharmacists Association, June 4, 2010    Free full text

20 Archivel Farma's TB Vaccine May Significantly Cut Treatment Time BioPharm, June 4, 2010    Free full text